These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31341236)

  • 1. Risk of therapy-related myelodysplastic syndrome/acute myeloid leukemia after childhood cancer: a population-based study.
    Advani PG; Schonfeld SJ; Curtis RE; Dores GM; Linet MS; Sigel BS; Lam CJK; Tucker MA; Chanock SJ; Morton LM
    Leukemia; 2019 Dec; 33(12):2947-2978. PubMed ID: 31341236
    [No Abstract]   [Full Text] [Related]  

  • 2. Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma.
    Jonsdottir G; Björkholm M; Turesson I; Hultcrantz M; Diamond B; Porwit A; Landgren O; Kristinsson SY
    Eur J Haematol; 2021 Aug; 107(2):275-282. PubMed ID: 33966293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of myelodysplastic syndrome and acute myeloid leukemia post radiation treatment for breast cancer: a population-based study.
    Kaplan H; Malmgren J; De Roos AJ
    Breast Cancer Res Treat; 2013 Feb; 137(3):863-7. PubMed ID: 23274844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.
    Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H
    Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased incidence of myelodysplastic syndrome and acute myeloid leukemia following breast cancer treatment with radiation alone or combined with chemotherapy: a registry cohort analysis 1990-2005.
    Kaplan HG; Malmgren JA; Atwood MK
    BMC Cancer; 2011 Jun; 11():260. PubMed ID: 21693006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why is there so much therapy-related AML and MDS and so little therapy-related CML?
    Gale RP; Hlatky L; Sachs RK; Radivoyevitch T
    Leuk Res; 2014 Oct; 38(10):1162-4. PubMed ID: 25175829
    [No Abstract]   [Full Text] [Related]  

  • 7. Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study.
    Takahashi K; Wang F; Kantarjian H; Doss D; Khanna K; Thompson E; Zhao L; Patel K; Neelapu S; Gumbs C; Bueso-Ramos C; DiNardo CD; Colla S; Ravandi F; Zhang J; Huang X; Wu X; Samaniego F; Garcia-Manero G; Futreal PA
    Lancet Oncol; 2017 Jan; 18(1):100-111. PubMed ID: 27923552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case-control study on the therapy of childhood cancer and the occurrence of second malignant neoplasms in Germany.
    Kaatsch P; Reinisch I; Spix C; Berthold F; Janka-Schaub G; Mergenthaler A; Michaelis J; Blettner M
    Cancer Causes Control; 2009 Aug; 20(6):965-80. PubMed ID: 19263232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and susceptibility to therapy-related myeloid neoplasms.
    Leone G; Fianchi L; Pagano L; Voso MT
    Chem Biol Interact; 2010 Mar; 184(1-2):39-45. PubMed ID: 20026017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility to therapy-related myelodysplastic syndromes and acute myeloid leukemia.
    Sill H
    Clin Adv Hematol Oncol; 2008 Mar; 6(3):164-5. PubMed ID: 18391913
    [No Abstract]   [Full Text] [Related]  

  • 11. Emerging trends of therapy related myeloid neoplasms following modern cancer therapeutics in the United States.
    Singh A; Herr MM; Griffiths EA; Przespolewski A; Faber MG; Mrad C; Wang ES; Hahn T; Thota S
    Sci Rep; 2021 Dec; 11(1):23284. PubMed ID: 34857802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary leukemia and myelodysplastic syndrome after treatment for Hodgkin's disease.
    Hoppe RT
    Leukemia; 1992 Nov; 6 Suppl 4():155-7. PubMed ID: 1434819
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy-related myelodysplasia and acute myeloid leukemia.
    Bhatia S
    Semin Oncol; 2013 Dec; 40(6):666-75. PubMed ID: 24331189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).
    Freedman RA; Seisler DK; Foster JC; Sloan JA; Lafky JM; Kimmick GG; Hurria A; Cohen HJ; Winer EP; Hudis CA; Partridge AH; Carey LA; Jatoi A; Klepin HD; Citron M; Berry DA; Shulman LN; Buzdar AU; Suman VJ; Muss HB
    Breast Cancer Res Treat; 2017 Jan; 161(2):363-373. PubMed ID: 27866278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy-related myeloid neoplasms following treatment with radioiodine.
    Schroeder T; Kuendgen A; Kayser S; Kröger N; Braulke F; Platzbecker U; Klärner V; Zohren F; Haase D; Stadler M; Schlenk R; Czibere AG; Bruns I; Fenk R; Gattermann N; Haas R; Kobbe G; Germing U
    Haematologica; 2012 Feb; 97(2):206-12. PubMed ID: 21993688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetics, not just previous therapy, determines the course of therapy-related myeloid neoplasms.
    Larson RA
    J Clin Oncol; 2012 Jul; 30(19):2300-2. PubMed ID: 22585693
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute leukemia arising after radioiodine treatment for thyroid cancer.
    Gilabert M; Prebet T
    Haematologica; 2012 Aug; 97(8):e28-9; author reply e30. PubMed ID: 22855847
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials.
    Koontz MZ; Horning SJ; Balise R; Greenberg PL; Rosenberg SA; Hoppe RT; Advani RH
    J Clin Oncol; 2013 Feb; 31(5):592-8. PubMed ID: 23295809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy-related acute myeloid leukemia and myelodysplastic syndrome among refractory germ cell tumor patients.
    Inoue Y; Nakamura T; Nakanishi H; Oishi M; Hongo F; Okihara K; Mizutani S; Kuroda J; Ukimura O
    Int J Urol; 2018 Jul; 25(7):678-683. PubMed ID: 29752743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent improvement in completeness of incidence data on acute myeloid leukemia in US cancer registries.
    Polednak AP
    J Registry Manag; 2014; 41(2):77-84. PubMed ID: 25153013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.